TROG Cancer Research
Members Login   CQMS Login

TROG 17.03 (LARK)


Liver Ablative Radiotherapy utilizing Kilovoltage intrafraction monitoring 


This study aims to show that incorporating Kilovoltage Intrafraction monitoring (KIM) in to liver SABR improves: treatment accuracy, patient treatment outcomes, and treatment efficiency.

Participating Centres

Current participating centres

Accrual Target


Current Accrual

Current accrual graph (PDF)

Expected Date of Accrual Completion


Trial chairperson

Dominique Lee, Princess Alexandra Hospital

Tim Wang, Crown Princess Mary Cancer Centre, Westmead

Trial contact

TROG Trial Coordinating Centre
Phone: +61 2 4014 3911

Primary Sponsor

University of Sydney

Trial resources for TROG members

LARK 17.03 member page


We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.